DCF — ADIRONDACK MEDICAL CENTER
Enterprise Value: $-257.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-257.7M
Enterprise Value
$-80.2M
PV of Cash Flows
$-177.4M
PV of Terminal Value
$-285.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $123.1M | $-16.8M | -14.0% | $-22.0M | $-20.0M |
| Year 2 | $126.8M | $-16.0M | -13.0% | $-21.4M | $-17.6M |
| Year 3 | $130.6M | $-15.2M | -12.0% | $-20.7M | $-15.5M |
| Year 4 | $134.6M | $-14.9M | -11.0% | $-20.6M | $-14.1M |
| Year 5 | $138.6M | $-15.0M | -11.0% | $-20.9M | $-13.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-257.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$119.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14103067280450135
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5